Mapování preskripce léčivých přípravků napříč Evropou
| Title in English | Mapping the prescription patterns of medicinal products across Europe |
|---|---|
| Authors | |
| Year of publication | 2025 |
| Type | Appeared in Conference without Proceedings |
| MU Faculty or unit | |
| Citation | |
| Description | Study objective: The findings presented are part of a broader questionnaire-based study that aimed to map the implementation of generic and brand names of medicines in pharmacology and clinical pharmacology teaching in European countries, the attitudes of teachers, and the influence of local prescribing rules on their use. Data on prescription practices and policies in individual countries are presented. Methodology: Data were collected via an online questionnaire structured into three main sections: characteristics of local prescribing practices, nomenclature of drugs used in teaching, and demographic profile. The questionnaire was distributed among pharmacology and clinical pharmacology teachers from 38 European countries. The collected data on local prescription rules were additionally verified through communication with national regulatory agencies. The agency's response was considered binding. Results: A total of 61 participants from 23 European countries took part in the study; half of them combined academic and clinical activities. In the case of 24 participants from 14 countries, a discrepancy was identified between their responses and those of the respective national regulatory agency. In all countries, physicians are authorized to prescribe; 31% of participants stated that nurses are authorized to prescribe, with midwives coming next in terms of frequency. With the exception of two countries with mandatory prescription using brand names, generic prescription is at least possible in all countries. Recent changes in the prescribing policy were reported by representatives from four countries. The possibility of generic substitution was reported by 95% of participants, while 50% reported that pharmacists have access to patients' medication histories. Differences between outpatient and inpatient prescribing were reported by 13 participants from 12 countries. Conclusion: This partial analysis provides a brief overview of prescribing practices across selected European countries. There is clear inconsistency in the rules, with the only commonality being that prescribing rights are restricted to physicians. There is a high degree of agreement on the implementation of generic substitution. Generic prescribing is allowed in more than 90% of the countries surveyed in 2025. Generic prescribing and substitution are more common in hospitals than in outpatient settings. In contrast to the above, the competences of pharmacists vary greatly from country to country. |
| Related projects: |